STAT3 targeting in dystrophic epidermolysis bullosa
Marie Guillou2024-10-16T10:08:30+02:00Publication - Epub 2019 Dec 2. STAT3 targeting in dystrophic epidermolysis bullosa Authors V R Mittapalli, T Kühl, S E Kuzet, C [...]
Publication - Epub 2019 Dec 2. STAT3 targeting in dystrophic epidermolysis bullosa Authors V R Mittapalli, T Kühl, S E Kuzet, C [...]
Publication - Epub 2020 Nov 17. IgE autoantibodies in serum and skin of non-bullous and bullous pemphigoid patients Authors A Lamberts, [...]
Inherited Epidermolysis Bullosa and skin fragility syndromes – Darier disease – Hailey-Hailey disease Research Currently recruiting clinical therapy trials for Epidermolysis Bullosa (October [...]
Publication - Epub 2020 Nov 1. Metascoring Hidradenitis suppurativa Authors M. Daoud, H. Njimi, F. Benhadou, M. Suppa, M. Daxhelet, J. [...]
Publication - 2020 Oct 17 International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate [...]
Publication - Epub 2020 Oct 16. Paraneoplastic autoimmune multiorgan syndrome (PAMS) Authors Dario Didona, Giovanni Di Zenzo, Pascal Joly Abstract Originally [...]
Publication - 2020 Oct 2. Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis Authors Johann E Gudjonsson, [...]
Severe cutaneous drug reactions (ToxiTEN) Patient documents SJS / TEN Patient Information Leaflet Recommended by the ERN-Skin 2019
Cutaneous Mosaic Disorders : Naevi & Naevoid skin disorders – Complex vascular malformations and cutaneous and subcutaneous vascular tumors Patient documents The documents [...]
Mendelian connective tissue disorders Patient documents No document yet